Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Elite Pharmaceuticals Inc ELTP

Healthcare
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and distributes niche generic products. The Company specializes in developing and manufacturing oral, controlled-release drug products. It owns multiple generic products which has been licensed to Prasco, LLC and TAGI Pharma. The Company’s segments include Abbreviated New Drug Applications (ANDA) and New Drug... see more

Recent & Breaking News (OTCQB:ELTP)

Elite Pharmaceuticals Files ANDA for Pain Product

GlobeNewswire April 4, 2017

Elite Pharmaceuticals, Inc. Initiates Pivotal Bioequivalence Fed Study for Reformulated SequestOx™

GlobeNewswire March 13, 2017

FinancialBuzz.com: Developments in the Biotechnology Market

PR Newswire February 14, 2017

Elite Pharmaceuticals, Inc. Reports Results for Third Quarter of Fiscal Year 2017

GlobeNewswire February 9, 2017

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2017 Financial Results on February 13, 2017

GlobeNewswire February 7, 2017

Elite Reports On SequestOx™ FDA End-of-Review Meeting

GlobeNewswire January 23, 2017

FinancialBuzz.com: Recent Developments in the World of Small Cap Companies

PR Newswire January 17, 2017

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study for a Generic OxyContin®

GlobeNewswire January 17, 2017

Elite Provides Update on SequestOx™ New Drug Application

GlobeNewswire December 22, 2016

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2017 and Provides Conference Call Information

GlobeNewswire November 9, 2016

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 2nd Quarter 2017 Financial Results on November 10, 2016

GlobeNewswire November 7, 2016

Elite Announces Development and License Agreement with SunGen Pharma LLC

GlobeNewswire August 29, 2016

Elite Pharmaceuticals files ANDA to Market Generic Percocet

GlobeNewswire August 10, 2016

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2017 and Provides Conference Call Information

GlobeNewswire August 9, 2016

FDA Issues Complete Response Letter for SequestOx™ New Drug Application

GlobeNewswire July 15, 2016

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2016 and Provides Conference Call Information

GlobeNewswire June 15, 2016

Elite Pharmaceuticals to Present SequestOx™ Data at the American Pain Society 35th Annual Scientific Meeting

GlobeNewswire May 9, 2016

Elite Pharmaceuticals Appoints Davis S. Caskey to Its Board of Directors

GlobeNewswire May 4, 2016

Elite Pharmaceuticals Announces Changes to their Board of Directors

GlobeNewswire April 12, 2016

Penny Stocks to Buy on St. Patrick's Day... If You So Choose

Accesswire March 17, 2016